Found 40 matching trials
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) PHASE3 This study will determine whether participants who receive the vaccine V419...
Show More Location
Multiple Locations
Learn More & Join Trial
Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) PHASE3 To evaluate the immune response and the safety of a primary series schedule...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) PHASE3 This is a study to assess the safety, tolerability, and immunogenicity of V...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand PHASE3 Primary Objective:
To demonstrate the non-inferiority of the SHAN6™ vaccin...
Show More Location
Investigational Site Number 7640003
Treatments Being Tested
DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus) DTwP-HepB-Hib pentavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b) Inactivated Poliomyelitis Vaccine Poliomyelitis Vaccine bivalent types 1 and 3 Human Rotavirus, live attenuated Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) Learn More & Join Trial
Baby Vaccine Study (Sched3) PHASE2 This multicentre, parallel group, block randomised clinical trial aims to i...
Show More Location
Centre for Clinical Vaccinology and Tropical Medicine
Learn More & Join Trial
Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age PHASE2 This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants PHASE2 Primary objectives:
* To assess the safety profile of each SP0202 formulat...
Show More Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Learn More & Join Trial
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age PHASE3 The purpose of the present study is to demonstrate that the changes in the ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study of the Interaction Between BCG And MenC Immunisation: BAM PHASE4 The Bacille Calmette-Guérin (BCG) vaccine is the only vaccine licenced to p...
Show More Location
University of Oxford, Oxford Vaccine Group
Treatments Being Tested
BCG, NeisVac-C®, Pediacel®, Infanrix™, Prevenar-13®, Menitorix®, Priorix®, Rotarix® BCG, NeisVac-C®, Pediacel®, Infanrix™, Prevenar-13®, Menitorix®, Priorix®, Rotarix® NeisVac-C®, Pediacel®, Infanrix™, Prevenar-13®, Menitorix®, Priorix®, Rotarix® Learn More & Join Trial
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US PHASE3 The purpose of this study was to compare the immunogenicity and describe th...
Show More Location
Birmingham Pediatric Associates Site Number : 8400026
Learn More & Join Trial